Skip to main content

Inclusive Capital takes a stake in Bayer — 3 ways it may build value with a sustainable focus

Jeff Ubben’s Inclusive Capital took a stake in Bayer. The pharmaceutical giant has a big footprint in the crop science space.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.